DDIs & Other Prescribing Issues, References

Specific References

1. American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2019;67:674-94

2. Sandkovsky S, Moore R, et al. Acceptable raltegravir and etravirine concentrations in plasma when administered via gastrostomy tube. Pharmacotherapy. 2012 Feb 31 (2); 142-147

3. Cattaneo D et al. AAC 2012

4. Jongbloed-de Hoon M et al. JAIDS 2017, 74 :571-574

5. Roskam-Kwint M et al. J Antimicrob Chemother 2018

6. Adkison K et al. 24th Conference on Retroviruses and Opportunistic Infections, Abstract 42

7. Brown K et al. EACS 2017

8. https://www.medicines.org.uk/emc/ (accessed on 28 May 2019)

9. Ashley C, Dunleavy A, editors. The Renal Drug Handbook. 5th ed. Boca Raton:CRC Press;2019

10. Holmes HM et al. Reconsidering medication appropriateness for patients late in life, Arch Intern Med 2006

11. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. J Am Geriatr Soc 2015

12. O’Mahony D et al. Age Ageing 2015

13. Good practice guidelines for the assessment and treatment of adults with gender dysphoria. Royal College of Psychiatrists, London, 2013, Document CR181

14. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. Hembree WC et al. J Clin Endocrinol Metab, 2009, 94(9):3132-54

15. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. Department of Family & Community Medicine, University of California, 2016

16. Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen. Meriggiola MC, Gava G. Clin Endocrinol (Oxf). 2015, 83(5):597-606

General References

None